These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 29440008)

  • 1. Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation.
    Frustaci A; De Luca A; Guida V; Biagini T; Mazza T; Gaudio C; Letizia C; Russo MA; Galea N; Chimenti C
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular noncompaction associated with hypertrophic cardiomyopathy: echocardiographic diagnosis and genetic analysis of a new pedigree in China.
    Yuan L; Xie M; Cheng TO; Wang X; Zhu F; Kong X; Ghoorah D
    Int J Cardiol; 2014 Jun; 174(2):249-59. PubMed ID: 24698237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular noncompaction in a family with lamin A/C gene mutation.
    Parent JJ; Towbin JA; Jefferies JL
    Tex Heart Inst J; 2015 Feb; 42(1):73-6. PubMed ID: 25873806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction.
    Hastings R; de Villiers CP; Hooper C; Ormondroyd L; Pagnamenta A; Lise S; Salatino S; Knight SJ; Taylor JC; Thomson KL; Arnold L; Chatziefthimiou SD; Konarev PV; Wilmanns M; Ehler E; Ghisleni A; Gautel M; Blair E; Watkins H; Gehmlich K
    Circ Cardiovasc Genet; 2016 Oct; 9(5):426-435. PubMed ID: 27625337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
    Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
    BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic disorder or toxoplasma myocarditis: a case report of dilated cardiomyopathy with hypertrabeculation in a young asymptomatic woman.
    Dobranici M; Buzea A; Popescu R; Chirila L
    J Med Life; 2012 Feb; 5(1):110-3. PubMed ID: 22574099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of myocardial dysfunction using three-dimensional speckle tracking echocardiography in a genetic positive hypertrophic cardiomyopathy Chinese family.
    Wang J; Guo RQ; Guo JY; Zuo L; Lei CH; Shao H; Wang LF; Zhang YM; Liu LW
    Cardiol Young; 2018 Sep; 28(9):1106-1114. PubMed ID: 29978770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
    Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
    J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing.
    Wu W; Lu CX; Wang YN; Liu F; Chen W; Liu YT; Han YC; Cao J; Zhang SY; Zhang X
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26163040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study.
    Girolami F; Iascone M; Tomberli B; Bardi S; Benelli M; Marseglia G; Pescucci C; Pezzoli L; Sana ME; Basso C; Marziliano N; Merlini PA; Fornaro A; Cecchi F; Torricelli F; Olivotto I
    Circ Cardiovasc Genet; 2014 Dec; 7(6):741-50. PubMed ID: 25173926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation.
    Luedde M; Ehlermann P; Weichenhan D; Will R; Zeller R; Rupp S; Müller A; Steen H; Ivandic BT; Ulmer HE; Kern M; Katus HA; Frey N
    Cardiovasc Res; 2010 Jun; 86(3):452-60. PubMed ID: 20083571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy associated with left ventricular noncompaction cardiomyopathy and coronary fistulae: a case report. One genotype, three phenotypes?
    Delgado A; Moreira D; Rodrigues B; Correia E; Gama P; Cabral C; Marinho A; Santos O
    Rev Port Cardiol; 2013 Nov; 32(11):919-24. PubMed ID: 24268868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of an infant with compound heterozygous mutations for hypertrophic cardiomyopathy producing a phenotype of left ventricular noncompaction.
    Haberer K; Buffo-Sequeira I; Chudley AE; Spriggs E; Sergi C
    Can J Cardiol; 2014 Oct; 30(10):1249.e1-3. PubMed ID: 25262865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
    Weissler-Snir A; Hindieh W; Gruner C; Fourey D; Appelbaum E; Rowin E; Care M; Lesser JR; Haas TS; Udelson JE; Manning WJ; Olivotto I; Tomberli B; Maron BJ; Maron MS; Crean AM; Rakowski H; Chan RH
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28193612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac adrenergic activity is associated with left ventricular hypertrophy in genetically homogeneous subjects with hypertrophic cardiomyopathy.
    Sipola P; Vanninen E; Aronen HJ; Lauerma K; Simula S; Jääskeläinen P; Laakso M; Peuhkurinen K; Kuusisto J; Kuikka JT
    J Nucl Med; 2003 Apr; 44(4):487-93. PubMed ID: 12679389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac α-Actin (ACTC1) Gene Mutation Causes Atrial-Septal Defects Associated With Late-Onset Dilated Cardiomyopathy.
    Frank D; Yusuf Rangrez A; Friedrich C; Dittmann S; Stallmeyer B; Yadav P; Bernt A; Schulze-Bahr E; Borlepawar A; Zimmermann WH; Peischard S; Seebohm G; Linke WA; Baba HA; Krüger M; Unger A; Usinger P; Frey N; Schulze-Bahr E
    Circ Genom Precis Med; 2019 Aug; 12(8):e002491. PubMed ID: 31430208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts.
    Swan H; Piippo K; Viitasalo M; Heikkilä P; Paavonen T; Kainulainen K; Kere J; Keto P; Kontula K; Toivonen L
    J Am Coll Cardiol; 1999 Dec; 34(7):2035-42. PubMed ID: 10588221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Gruner C; Chan RH; Crean A; Rakowski H; Rowin EJ; Care M; Deva D; Williams L; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Siminovitch K; Ralph-Edwards AC; Rastegar H; Maron BJ; Maron MS
    Eur Heart J; 2014 Oct; 35(39):2706-13. PubMed ID: 24810389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy.
    Captur G; Lopes LR; Mohun TJ; Patel V; Li C; Bassett P; Finocchiaro G; Ferreira VM; Esteban MT; Muthurangu V; Sherrid MV; Day SM; Canter CE; McKenna WJ; Seidman CE; Bluemke DA; Elliott PM; Ho CY; Moon JC
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):863-71. PubMed ID: 25228707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.